All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
AngioDynamics (Albany, New York) said it has received clearance for its BioFlo Port with Endexo technology, a device designed to reduce the accumulation of cather-related thrombus on, and in, the port catheter. The company said the clearance of the BioFlo Port with Endexo technology marks the second U.S. clearance of a product line developed with BioFlo's technology.